Patent · US Expired

Systems, methods and devices for in vivo monitoring of a localized response via a radiolabeled analyte in a subject

US7011814B2 · kind B2 · utility

70Cited by
144References
50Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 22, 2002
Grant dateMar 14, 2006
Priority date
Expiry dateApr 6, 2023

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61B6/508
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods, systems, devices and computer program products monitor in vivo detected radiation in a target localized site within a subject, over a selected time period, to do one or more of: (a) quantify a radiation dose received at a local site; (b) assess bioreceptiveness to a particular treatment time or type; (c) evaluate the pharmacokinetics of a radiolabeled analyte corresponding to a non-radiolabeled analyte; (d) monitor or evaluate metabolic activity; or (e) evaluate a tumor prior to or after a therapeutic treatment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.